Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/13 → 5/1/14 |
Funding
- BioMarin Pharmaceutical Inc.
EAP: A Multicenter, Open-label BMN 110 US Expanded Access Program (BMN 110 US EAP) to Provide BMN 110 to Patients Diagnosed with MPS IVA
- Burton, Barbara K (PD/PI)
- Charrow, Joel (Co-Investigator)
Project: Research project